

Alvio Pharmaceuticals Private Limited loan details
Charges taken from banks & financial institutesData last updated:
Alvio Pharmaceuticals Private Limited has 10 charges registered with the Registrar of Companies: 9 open charges worth Rs 16.46 Cr and 1 satisfied charge worth Rs 2.50 M. The most recent charge was created on 31 Jan 2025 for Rs 9.20 M and is open.
Charges Breakdown by Lending Institutions
- Others : 16.46 Cr
₹16.46 crore
₹0.25 crore
1
Others
Modification
02 Jul 2025
₹9.50 cr
| Charge Id | Lender | Amount | Creation Date | Last Modification Date | Satisfaction Date | Status |
|---|---|---|---|---|---|---|
| 100360043 View Details | Others | ₹ 0.25 | 27 Apr 2020 | - | 19 Dec 2023 | Satisfied |
| 101056259 View Details | Others | ₹ 0.92 | 31 Jan 2025 | - | - | Open |
| 100812361 View Details | Others | ₹ 0.15 | 12 Oct 2023 | - | - | Open |
| 100539216 View Details | Others | ₹ 4.00 | 24 Feb 2022 | - | - | Open |
| 100541527 View Details | Others | ₹ 0.64 | 22 Feb 2022 | - | - | Open |
| 100517783 View Details | Others | ₹ 0.10 | 15 Dec 2021 | - | - | Open |
| 100448978 View Details | Others | ₹ 0.15 | 10 Jun 2021 | - | - | Open |
| 100361232 View Details | Others | ₹ 0.32 | 11 Jun 2020 | - | - | Open |
| 100122846 View Details | Others | ₹ 9.50 | 11 Sep 2017 | 02 Jul 2025 | - | Open |
| 100092735 View Details | Others | ₹ 0.69 | 20 Apr 2017 | 28 Feb 2018 | - | Open |
Premium access Charge documents and asset detailsThe filed charge documents and the assets pledged under each charge are in the company report.
Verified entity values are shown only after access is granted. | ||||||
A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.